| Jeffrey J. Kraws |
Founder of Crystal Research Associates, TopHat Capital LLC and Cra Advisors LLC, Jeffrey J. Kraws is an entrepreneur and businessperson who has been at the helm of 8 different companies and presently holds the position of Independent Non-Executive Chairman for Synthetic Biologics, Inc., Chief Executive Officer at Crystal Research Associates, Chief Executive Officer for Cra Advisors LLC, Chief Executive Officer & Director at Innovation1 Biotech, Inc. and Partner at TopHat Capital LLC. Mr. Kraws is also Partner at Phoenix Holdings Ltd. (US), Partner at Grannus Securities Pty Ltd. and Partner at US Medical Innovations LLC.
In his past career he held the position of Independent Chairman for Avivagen, Inc., President of IRG Research Group, President for Ra Medical Systems, Inc., President-Brokerage & Investment Banking Operation at Abb Aros Securities, Inc., Senior Analyst at The Buckingham Research Group, Inc., Co-President at The Investor Relations Group, Inc., Managing Director-Healthcare Research at Ryan, Beck & Co., Inc., MD-Healthcare Research Group at First Union Securities and Managing Director & Research Director at Gruntal & Co. LLC.
He received an MBA from Cornell University and an undergraduate degree from State University of New York at Buffalo. |
| Frank Tufaro |
Frank Tufaro is an entrepreneur and businessperson who founded Nurel Therapeutics, Inc., Medigene, Inc. and NeuroVir Therapeutic, Inc. and who has been at the helm of 5 different companies. He occupies the position of Chief Operating Officer for Synthetic Biologics, Inc. He is also on the board of Protocol Intelligence, Inc.
Frank Tufaro previously occupied the position of Chief Executive Officer at Allera Health Products, Inc., President, Chief Executive Officer & Director at DNAtrix, Inc., President at Opa Therapeutics, Inc., President & Chief Executive Officer of Nurel Therapeutics, Inc., Chief Executive Officer of NeuroVir Therapeutic, Inc., Chief Operating Officer of VCN Biosciences SL and Professor-Microbiology & Immunology at the University of British Columbia.
Frank Tufaro received a doctorate and an undergraduate degree from McGill University. |
| Jeff A. Wolf |
Jeff A. Wolf is an entrepreneur and businessperson who founded 9 companies, notably: NightHawk Biosciences, Inc., Avigen, Inc. and Seed-One Ventures LLC and who has been at the head of 6 different companies. Mr. Wolf occupies the position of Chairman, President & Chief Executive Officer for NightHawk Biosciences, Inc. (which he founded in 2008). Jeff A. Wolf is also on the board of Elusys Therapeutics, Inc. (former Chairman), Pelican Therapeutics, Inc. and Synthetic Biologics, Inc.
In the past Mr. Wolf was Chairman & Chief Executive Officer of GenerationOne, Inc. (he founded the company), Managing Director at Sunrock Equity Partners LLC, Managing Director at Seed-One Ventures LLC (he founded the company in 1997), Chairman & Chief Executive Officer at Elusys Therapeutics, Inc. (he founded the company), Chairman of TYRX, Inc. (he founded the company in 1998), Managing Director at Castle Group Ltd. and Director at Avigen, Inc.
He received an undergraduate degree from The University of Chicago, a graduate degree from New York University School of Law and an MBA from Stanford Graduate School of Business. |
| John James Monahan |
John James Monahan founded Avigen, Inc. and Tacere Therapeutics, Inc. Dr. Monahan is on the board of NightHawk Biosciences, Inc. and 4 other companies.
In the past he was Director-Molecular & Cell Biology at Triton Biosciences, Inc., Chief Executive Officer for Avigen, Inc., Vice President-Research & Development at Somatix Therapy Corp., Group Chief-Molecular Genetics at Hoffmann-La Roche, Inc. and Director at Tacere Therapeutics, Inc.
Dr. Monahan received a doctorate from McMaster University and an undergraduate degree from University College Dublin. |
